A Phase 3 Randomized Trial Evaluating Alirocumab 300 mg...

Journal of Clinical Lipidology 2016 / 05 Vol. 10; Iss. 3

A Phase 3 Randomized Trial Evaluating Alirocumab 300 mg Every 4 Weeks (Q4W) as Monotherapy or Add-On to Statin: ODYSSEY CHOICE I

Roth, Eli M., Moriarty, Patrick, Bergeron, Jean, Langslet, Gisle, Manvelian, Garen, Zhao, Jian, Baccara-Dinet, Marie, Rader, Daniel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Journal of Clinical Lipidology
DOI:
10.1016/j.jacl.2016.03.094
Date:
May, 2016
File:
PDF, 359 KB
english, 2016
Conversion to is in progress
Conversion to is failed